Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

September 16, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • NK cells can potentiate anti–tumour responses

PGIMER Recruitment | SRF Post For Life Science / Molecular Biology

IISER Mohali Molecular Biology Research Associate Job Recruitment

NK cells can potentiate anti–tumour responses
  • BiotechToday
  • World

NK cells can potentiate anti–tumour responses

bioxone November 25, 2020November 25, 2020

Prama Ghosh, Amity University Kolkata

Past proof in mice has exhibited that NK cell-inferred IFN-gamma can advance immunoevasion by chiselling the immunogenicity of creating tumours in a process known as cancer immunoediting. This process includes the disposal of the high immunogenic unedited tumour, followed by the inevitable break of less immunogenic altered tumour cell variants that can get away from recognition or elimination by the immune system.

Cancer immunosurveillance is a process in which natural killer (NK) cells, innate lymphocytes which patrol host tissues against transformed cells. According to research, fibrosarcomas edited by NK cells- decrease the expression of 17 conserved IFN-gamma-inducible genes as compared to unedited tumour cells. Three genes, namely, Psmb8, Trim21, Parp12, have been identified whose high-expression in tumour samples enhances the survival of patients with breast cancer, melanoma, and sarcoma.

While NK cell-altered fibrosarcomas showed protection from IFN-gamma-mediated development suspension in vitro, functional knockouts of individual interferon-stimulated genes (ISGs) were not needed for the outgrowth of unedited tumour cell lines in vitro and in vivo contrasted with complete loss of IFN signalling. Moreover, knockout of IFN-gamma-intrinsic signalling using erasure of Ifngr in altered B16 F10 and E0771 LMB metastatic cancer cell lines did not affect the survival of the host following lung metastasis. 

Together, these outcomes recommend that unedited tumours can be chosen for decreased IFN-gamma signalling to sidestep immune responses in vivo and, as a result, tumour-extrinsic IFN signalling might be more significant for potentiating durable anti-tumour responses to solid tumours.

Also read: Comparison of Powersoil and MagMAX2

Reference: NK cells promote cancer immunoediting through tumour-intrinsic loss of interferon-stimulated gene expression, Yung Yu Wong, Luke Riggan, Christopher Huerta, Matthew Moldenhauer, Edgar Perez Reyes, Timothy E O’Sullivan, bioRxiv 2020.11.23.394353; 

doi: https://doi.org/10.1101/2020.11.23.394353

  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged anti-tumour response cancer cancer treatment cell lines fibrosarcomas immune system immunoediting metastasis natural killer cells tumour cells

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Job and Internship
  • Signaling Pathway

IISER Mohali Molecular Biology Research Associate Job Recruitment

bioxone November 25, 2020

-Shristi Sharma, Team bioXone IISER Mohali Molecular Biology Research Associate Job Recruitment. Research Associate vacancies for Molecular Biology candidates. PDF jobs. IISER Mohali is recruiting mol bio candidates for a project vacancy as per the details given below: IISER Job Details Name of the Position: Research Associate Number of Post: One Title of project: A […]

ICMR JRF

Related Post

  • BiotechToday
  • World

J&J COVID-19 vaccine: A potential disaster for humans

bioxone July 14, 2021July 14, 2021

Saptaparna Dasgupta, Bennett University The COVID-19 vaccine has been created as an emergency vaccine, based on several strategies, such as mRNA vaccine, inactivated virus vaccine, etc. The other vaccines having cleared the clinical trials have passed on to the mass population vaccination drives, without any reported risk factors, yet. However, Johnson and Johnson’s COVID 19 […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

ECMO: An artificial heart-lung set for COVID-19 treatment

bioxone June 22, 2021June 23, 2021

Avani Dave, Jai Hind College Extracorporeal membrane oxygenation (ECMO) acts as an artificial set of the heart and lungs, allowing a patient’s respiratory foundation to rest while proceeding towards a hopeful recovery. This mechanism has been put in a good word for, particularly during the two consecutive and rampant waves of the COVID-19 pandemic. ECMO […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

ANIMAL-FREE MONOCLONAL ANTIBODY- A SUBSTITUTE FOR HYBRIDOMA TECHNOLOGY?

bioxone October 8, 2020October 7, 2020

PRIYANKA CHAKRABORTY, AMITY UNIVERSITY KOLKATA Hybridoma Technology is known for its’ large-scale production of identical antibodies. Recently, the European Commission’s Joint Research Centre (EC-JRC) urged the government to allow the development of animal-free antibodies for the production of vaccine development. This came after the work done by the Scientific Advisory Committee (ESAC) and claims were […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy